Reynders, McVeigh Core Equity Fund ABT Holdings History
Reynders, McVeigh Core Equity Fund's Abbott Laboratories Holding Summary
As of 2025-04-30, Capitol Series Trust held 18,912.00 shares of Abbott Laboratories(ABT), totaling $2.47 Mil. This investment constitutes 3.02% of their stock portfolio, and Capitol Series Trust now holds 0% of the outstanding Abbott Laboratories(ABT) stock.
The initial trade took place in 2020Q2. And since then Reynders, McVeigh Core Equity Fund has made 15 purchases of ABT, at an average price of $98.23, for a total of 18,912.00 shares. Based on historical transaction data and ABT's current price of $123.67, Reynders, McVeigh Core Equity Fund's estimated gain on his ABT holdings is $481,194.40, reflecting a 25.90% gain to date.
Reynders, McVeigh Core Equity Fund ABT ($123.67) Holding Chart
Reynders, McVeigh Core Equity Fund ABT ($123.67) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
